Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)

Iron‐deficiency anemia is a potent stimulator of the phosphaturic hormone Fibroblast growth factor‐23 (FGF23). Anemia, elevated FGF23, and elevated serum phosphate are significant mortality risk factors for patients with chronic kidney disease (CKD). However, the contribution of anemia to overall ci...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Physiol Rep
Main Authors: Noonan, Megan L., Clinkenbeard, Erica L., Ni, Pu, Swallow, Elizabeth A., Tippen, Samantha P., Agoro, Rafiou, Allen, Matthew R., White, Kenneth E.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7261757/
https://ncbi.nlm.nih.gov/pubmed/32476270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.14434
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki